buspirone has been researched along with Agoraphobia in 11 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This multicentre study compared a 16-week buspirone treatment with placebo in patients presenting with panic disorder with agoraphobia and also receiving cognitive behaviour therapy (CBT)." | 9.08 | A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. ( Bernard, G; Bouvard, M; Chneiweiss, L; Cottraux, J; Cungi, C; Heim, F; Légeron, P; Note, ID, 1995) |
| "This multicentre study compared a 16-week buspirone treatment with placebo in patients presenting with panic disorder with agoraphobia and also receiving cognitive behaviour therapy (CBT)." | 5.08 | A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. ( Bernard, G; Bouvard, M; Chneiweiss, L; Cottraux, J; Cungi, C; Heim, F; Légeron, P; Note, ID, 1995) |
| "Thirty-six patients with generalised anxiety disorder, panic disorder or agoraphobia with panic attacks, diagnosed by DSM-III criteria, were treated with a new non-benzodiazepine anti-anxiety drug, buspirone, and with diazepam and placebo, in a cross-over design." | 5.05 | Anxiety in primary care: is short-term drug treatment appropriate? ( Owen, R; Tyrer, P, 1984) |
| "Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients." | 2.67 | Is buspirone effective for panic disorder? ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1990) |
| "Panic disorder is characterised by recurrent unexpected panic attacks consisting of a wave of intense fear that reaches a peak within a few minutes." | 2.61 | Benzodiazepines versus placebo for panic disorder in adults. ( Barbui, C; Bighelli, I; Breilmann, J; Castellazzi, M; Cipriani, A; Davies, SJ; Furukawa, TA; Girlanda, F; Guaiana, G; Koesters, M, 2019) |
| "Panic disorder is common in the general population." | 2.50 | Azapirones versus placebo for panic disorder in adults. ( Barbui, C; Bighelli, I; Castellazzi, M; Chen, P; Cipriani, A; Furukawa, TA; Girlanda, F; Guaiana, G; Imai, H; Koesters, M; Pompoli, A; Tajika, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breilmann, J | 1 |
| Girlanda, F | 2 |
| Guaiana, G | 2 |
| Barbui, C | 2 |
| Cipriani, A | 2 |
| Castellazzi, M | 2 |
| Bighelli, I | 2 |
| Davies, SJ | 1 |
| Furukawa, TA | 2 |
| Koesters, M | 2 |
| Imai, H | 1 |
| Tajika, A | 1 |
| Chen, P | 1 |
| Pompoli, A | 1 |
| Dannawi, M | 1 |
| Dinan, T | 1 |
| Tyrer, P | 1 |
| Owen, R | 1 |
| Cottraux, J | 2 |
| Note, ID | 1 |
| Cungi, C | 1 |
| Légeron, P | 1 |
| Heim, F | 1 |
| Chneiweiss, L | 1 |
| Bernard, G | 1 |
| Bouvard, M | 2 |
| Mollard, E | 1 |
| Guerin, J | 1 |
| Sheehan, DV | 1 |
| Raj, AB | 1 |
| Sheehan, KH | 1 |
| Soto, S | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Gershon, S | 1 |
| Teicher, MH | 1 |
| Rickels, K | 1 |
4 reviews available for buspirone and Agoraphobia
| Article | Year |
|---|---|
Benzodiazepines versus placebo for panic disorder in adults.
Topics: Adult; Aged; Agoraphobia; Benzodiazepines; Buspirone; Humans; Imipramine; Middle Aged; Numbers Neede | 2019 |
Azapirones versus placebo for panic disorder in adults.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Buspirone; Humans; Panic Disorder; Randomized Controlled Tr | 2014 |
Therapeutic options: Addressing the current dilemma.
Topics: Adrenergic Uptake Inhibitors; Agoraphobia; Algorithms; Anti-Anxiety Agents; Antidepressive Agents; A | 2006 |
Biology of anxiety.
Topics: Agoraphobia; Anxiety Disorders; Buspirone; Fear; Humans; Panic; Phobic Disorders; Receptors, GABA-A | 1988 |
5 trials available for buspirone and Agoraphobia
| Article | Year |
|---|---|
Anxiety in primary care: is short-term drug treatment appropriate?
Topics: Adult; Agoraphobia; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Female; Humans | 1984 |
A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia.
Topics: Adolescent; Adult; Agoraphobia; Anti-Anxiety Agents; Buspirone; Cognitive Behavioral Therapy; Depres | 1995 |
Study and course of the psychological profile in 77 patients expressing panic disorder with agoraphobia after cognitive behaviour therapy with or without buspirone.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Buspirone; Cognitive Behavioral Therapy; Combined Modality | 1997 |
Is buspirone effective for panic disorder?
Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Buspirone; Double-Blind Method; Fear; Female; Follow | 1990 |
Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
Topics: Adult; Agoraphobia; Brain; Buspirone; Clinical Trials as Topic; Double-Blind Method; Fear; Female; H | 1989 |
2 other studies available for buspirone and Agoraphobia
| Article | Year |
|---|---|
Possible serotonin syndrome after combination of buspirone and St John's Wort.
Topics: Adult; Agoraphobia; Buspirone; Drug Interactions; Female; Humans; Hypericum; Psychiatric Status Rati | 2002 |
Clinical studies of "specific" anxiolytics as therapeutic agents.
Topics: Agoraphobia; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Mental Diso | 1987 |